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Non-thermal atmospheric plasma induces
ROS-independent cell death in U373MG
glioma cells and augments the cytotoxicity of
temozolomide
Gillian E Conway*,1,2,3, Alan Casey3, Vladimir Milosavljevic1, Yupeng Liu4, Orla Howe3,5, Patrick J Cullen1,6
and James F Curtin*,1,2
1BioPlasma Research Group, School of Food Science and Environmental Health, Dublin Institute of Technology, Dublin, Ireland;
2Environmental Sustainability and Health Institute, Dublin Institute of Technology, Dublin, Ireland; 3FOCAS Research Institute,
Dublin Institute of Technology, Dublin, Ireland; 4School of Computing, Dublin Institute of Technology, Dublin, Ireland; 5School of
Biological Sciences, Dublin Institute of Technology, Dublin, Ireland and 6School of Chemical Engineering, UNSW, Sydney,
Australia
Background: Non-thermal atmospheric plasma (NTAP) is an ionised gas produced under high voltage that can generate short-
lived chemically active species and induce a cytotoxic insult in cancer cells. Cell-specific resistance to NTAP-mediated cytotoxicity
has been reported in the literature. The aim of this study was to determine whether resistance against NTAP could be overcome
using the human glioma cell line U373MG.
Methods: Non-thermal atmospheric plasma was generated using a Dielectric Barrier Device (DBD) system with a maximum
voltage output of 120 kV at 50Hz. The viability of U373MG GBM cells and HeLa cervical carcinoma cells was determined using
morphology, flow cytometry and cytotoxicity assays. Fluorescent probes and inhibitors were used to determine the mechanisms of
cytotoxicity of cells exposed to the plasma field. Combinational therapy with temozolomide (TMZ) and multi-dose treatments
were explored as mechanisms to overcome resistance to NTAP.
Results: Non-thermal atmospheric plasma decreased cell viability in a dose (time)-dependent manner. U373MG cells were shown
to be resistant to NTAP treatment when compared with HeLa cells, and the levels of intracellular reactive oxygen species (ROS)
quantified in U373MG cells were much lower than in HeLa cells following exposure to the plasma field. Reactive oxygen species
inhibitor N-acetyl cysteine (NAC) only alleviated the cytotoxic effects in HeLa cells and not in the relatively NTAP-resistant cell line
U373MG. Longer exposures to NTAP induced a cell death independent of ROS, JNK and caspases in U373MG. The relative
resistance of U373MG cells to NTAP could be overcome when used in combination with low concentrations of the GBM
chemotherapy TMZ or exposure to multiple doses.
Conclusions: For the very first time, we report that NTAP induces an ROS-, JNK- and caspase-independent mechanism of cell
death in the U373MG GBM cell line that can be greatly enhanced when used in combination with low doses of TMZ. Further
refinement of the technology may facilitate localised activation of cytotoxicity against GBM when used in combination with new
and existing chemotherapeutic regimens.
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Glioblastoma multiforme (GBM) is classified as a malignant grade
IV astrocytoma (Louis et al, 2007), and is considered to be the most
biologically aggressive brain tumour that accounts for approxi-
mately 16% of all brain tumours (Dolecek et al, 2012). According
to the 2014 Central Brain Tumor Registry of United States
(CBRTUS) report, GBM makes up approximately 45.6% of all
primary malignant brain tumours. The prognosis for patients
diagnosed with GBM is bleak with a 5-year survival rate ofo10%
(Ostrom et al, 2014). The current standard of care for GBM is
maximal surgical resection followed by radiotherapy and con-
comitant and adjuvant chemotherapy using temozolomide (TMZ)
(Adamson et al, 2009). Treatment for GBM is limited due to the
inability of most chemotherapeutics to cross the blood brain
barrier to the site of the tumour and failure to successfully remove
all surrounding tumour cells during surgical resection (Candolfi
et al, 2007). Thus, survival rates have remained relatively stagnant
over the past 30 years (Carrabba et al, 2009). Recent statistics
provided by Ostrom et al (2014) show that patients diagnosed have
a 1-year survival rate of 36.5%, which drops dramatically after 3
years to 8.7%, indicating the urgency for the development of new
therapies.
Over the past decade, plasma science has emerged as a novel
approach for applications in areas such as food sterilisation,
medical devices, polymer science and biomedicine (von Woedtke
et al, 2013; Ziuzina et al, 2014). Physical plasmas are fully or
partially ionised gases that contain various concentrations of free
electrical charges, atoms, ions and electrons, which are generated
by an energy supply to a neutral gas (von Woedtke et al, 2013).
Plasmas can be categorised as either thermal or non-thermal. Non-
thermal plasma (NTP) gains its reactivity from the high energy
electrons while the ions and neutral species remain at a low
temperature (von Woedtke et al, 2013). NTPs attained at low or
atmospheric pressure have low power requirements and are also
able to generate chemically active species within gasses such as
reactive oxygen species (ROS) (O2
, O, and O3, OH
, H2O2) and
reactive nitrogen species (RNS) (NO3, N
þ
2, NO). The operating
principle of the plasma discharge system used is Dielectric Barrier
Discharge (DBD), which generates high voltage pulsed non-
thermal plasma between two electrodes, one of which is insulated.
The insulator prevents the build-up of current between the
electrodes and any significant gas heating (Fridman et al, 2006).
Non-thermal atmospheric plasma can effectively control the
concentrations of intracellular ROS/RNS. Non-thermal atmospheric
plasma-generated NO species results in the elevation of intracellular
NO concentration, which therefore leads to an increase in
intracellular ROS (Vandamme et al, 2012; Ishaq et al, 2014).
Reactive oxygen species are naturally present in the body and at
low concentrations mediate many biological functions including
cellular redox signalling, and high concentrations of ROS are
utilised as a cytotoxic mechanism by innate immune cells (Ahn
et al, 2011). To prevent cellular damage and apoptosis due to the
high reactivity of ROS, the cell contains antioxidant enzymes such
as glutathione peroxidase, which act as scavengers to detoxify ROS
(King and Robins, 2006). Over the years, it has become
increasingly apparent that the generation of ROS can be utilised
therapeutically for the treatment of cancer (Curtin et al, 2002).
Temozolomide is an alkylating agent, used in the treatment of
GBM that induces cell death by an ROS/ERK-mediated apoptosis
(Lin et al, 2012). A recurring issue with the current chemother-
apeutics used in the treatment for GBM is the adverse side effects
induced due to the high toxicity of the drugs, and developed
resistance to the therapeutic over time. Combinational therapies
are used with the aim to reduce the likelihood of developing drug
resistance and reduce the adverse side effects associated with single
agent therapies. It is hypothesised that NTAP offers great potential
as a possible combinational therapy for the treatment of GBM due
to the wide variety of biological processes affected.
Recent studies have shown that high concentrations of ROS
produced from NTAP exposure can generate a cytotoxic effect and
induce apoptosis of cancer cells via disruption of the mitochondrial
membrane (Fridman et al, 2008; Ahn et al, 2011; Vandamme et al,
2012; Ko¨ritzer et al, 2013). An important feature that has been
demonstrated in previous studies is that NTAP not only has the
ability to induce cell death in GBM cells but also has a much lower
cytotoxic effect on normal astrocytes (Recek et al, 2015; Siu et al,
2015). Although there is vast potential for the use of NTAP both as
a single agent and as a combinational therapy in the treatment of
cancers, experimental evidence supporting this application in GBM
remains to be carried out. The aim of this study is to evaluate the
antitumour effects of NTAP using a DBD system in vitro on
U373MG glioblastoma cells, and to determine the efficacy of a
combinational approach using TMZ.
MATERIALS AND METHODS
Cell culture. Human glioblastoma (U373MG-CD14) cells were
obtained from Dr Michael Carty (Trinity College Dublin). Human
cervical cancer (HeLa, ATCC CCL-2) cells were purchased from
American Type Culture Collection (LGC Standards, Middlesex,
UK). U373MG cells were cultured in DMEM (Sigma-Aldrich,
Arklow, Ireland) supplemented with 10% FBS (Sigma-Aldrich).
HeLa cells were cultured in RPMI-1640 (Sigma-Aldrich) with 10%
FBS. Both cell lines were maintained in a humidified incubator
containing 5% CO2 at 37 1C. Media was changed every 2–3 days
until 80% confluency was reached. Cells were routinely sub-
cultured using a 1 : 1 ratio of 0.25% trypsin (Sigma-Aldrich) and
0.1% EDTA (Sigma-Aldrich) (0.1 g EDTA in 500 ml PBS).
NTAP device. The NTAP-DBD device used (Figure 1A) is a novel
prototype atmospheric low temperature plasma generator (Ziuzina
et al, 2013). The system consists of a variable high voltage
transformer with an input voltage of 230V at 50Hz and a
maximum high voltage output of 120 kV. The two 15-cm-diameter
aluminium disc electrodes were separated by a polypropylene
sheet, which served both as a sample holder and as a dielectric
barrier with a thickness of 1–2mm. The distance between the two
electrodes was 14.2–26.6mm depending on the size of culture plate
used. Voltage was monitored using an InfiniVision 2000 X-Series
Oscillo-scope (Agilent Technologies Inc., Santa Clara, CA, USA).
The atmospheric air condition at the time of treatment was 45%
relative humidity (RH) and 22 1C. The samples were treated at
75 kV for 0–300 s. Optical emission spectroscopy (OES) readings
(Supplementary Figure 1) were taken between the range of 200
and 850 nm using the Low Straylight Smart CCD Exemplar
LS spectrophotometer (B&W Tek, Inc., Newark, DE, USA;
BRC115U), with a 3000-m/s integration time. Data were analysed
using BWSpec4 (B&W Tek, Inc.) and OriginPro 8 (OriginLab
Corporation, Northampton, MA, USA).
Cell viability assays. U373MG cells were seeded at a density of
1 104, and HeLa cells were seeded at 0.8 104 into 96-well plates
(Sigma-Aldrich) and allowed to adhere overnight. Media was removed
for the duration of NTAP treatment, and fresh media was replaced
immediately after treatment and incubated at 37 1C as indicated. No
deleterious effects were observed in the vehicle control samples.
Cell viability was analysed using Alamar Blue, a redox
fluorogenic indicator of metabolic reduction (Fischer Scientific,
Ballycoolin, Ireland) (Page et al, 1993). Cells were washed once
with sterile PBS, incubated for 2.5 h at 37 1C with a 10% Alamar
blue solution, and fluorescence was measured using an excitation
wavelength of 530 nm and an emission wavelength of 595 nm on a
Victor 3V 1420 (Perkin Elmer, Waltham, MA, USA) multi-plate
reader. The Trypan Blue (Biosciences, Dun Laoghaire, Ireland) cell
dye exclusion assay was also performed 48 h post treatment in
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HeLa cells and 96 h post treatment in U373MG cells. Both floating
and trypsinised cells were collected, and a 1 106 cell per ml cell
suspension was prepared. A 1 : 1 mixture of cell suspension and
0.4% trypan blue was loaded onto a haemocytometer for counting.
JC-1 apoptosis assay. After treatment, cells were harvested and
stained with 10 mgml 1 JC-1 dye (Biosciences, Dublin, Ireland)
(Galluzzi et al, 2007), at room temperature for 10min and analysed
by flow cytometry (BD Accuri C6, BD Biosciences, Erembodegem,
Belgium). JC-1 was excited using the argon laser at a wavelength of
488 nm. Fluorescence was measured using the FL1 (530 nm) and
FL2 (585 nm) channels with emission spectral overlap compensa-
tion (7.5% FL1/FL2 and 15% FL2/FL1).
Fluorescent probes. Reactive oxygen species generation was
determined using the cell permeable non-fluorescent probe
H2DCFDA (Biosciences, Dublin, Ireland) (Wu and Yotnda,
2011). Cells were plated in black flat-bottomed 96-well plates
(Fischer Scientific) overnight and preloaded with 10 mM H2DCFDA
for 1 h. Cells were washed once with PBS and exposed to NTAP for
180 s at 75 kV or treated with H2O2 where indicated. After NTAP
treatment, media was added to the wells and fluorescence intensity
was measured 1 h later on a micro-plate reader (Victor 3V) at 492–
495/517–527 nm. For fluorescent images, U373MG and HeLa cells
were plated in 35mm glass bottom dishes (MatTek Corporation,
Ashland, MA, USA) at 5 104 and 8 104 cells per dish
respectively and left for 24 h. Cells were preloaded and treated as
stated above and analysed using confocal microscopy (ZEISS LSM
510 Meta, Carl Zeiss, Oberkochen, Germany). Images were
captured using an excitation wavelength 488 nm and an emission
wavelength of 515 nm with a  40 objective. ROS was quantified
on the flow cytometer using H2DCFDA. Cells stained with 0.1mM
H2DCFDA for 30min before NTAP treatment. One hour post
treatment, cells were harvested and analysed by flow cytometry.
Fluorescence was measured using the FL1 channel (530 nm).
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Figure 1. NTAP dose-dependent cytotoxicity of HeLa and GBM cells. (A) Schematic of the DBD-NTAP set-up used in this study, and a photograph
showing plasma generation which fluoresces in the presence of helium gas. (B) Both U373MG cells and HeLa cells were exposed to NTAP at 75kV for up
to 5min. Forty-eight hours later, the cells were analysed using the Alamar Blue cell viability assay. All experiments were repeated a minimum of three
times. Statistical analysis was carried out using non-linear regression analyses. (C) Both U373MG cells and HeLa cells were exposed to NTAP at 75kV for
up to 180 s. HeLa cells were trypsinised and counted using a haemocytometer 48h post treatment. U373MG cells were analysed 96h post treatment. All
experiments were repeated a minimum of three times. Statistical analysis was carried out using non-linear regression analyses. (D) HeLa and U373MG
cells were exposed to NTAP at 75kV for 3min. After a 48-h incubation period, cells were loaded with 1mgml1 JC-1 dye and analysed by flow
cytometry. Data shown depict apoptosis measured by quantitative shifts in the DCm (red to green) fluorescence intensity ratio before and after H2O2
and NTAP expsoure. All experiments were repeated in triplicate. Statistical analysis was carried out using one-way ANOVA with Tukey’s multiple
comparison post-test (*Po0.05). A full colour version of this figure is available at the British Journal of Cancer journal online.
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Mitochondrial ROS production was determined using MitoSOX
Red (Biosciences, Dublin, Ireland). Cells were loaded with 2 mM
MitoSOX red, a mitochondrial superoxide indicator. Cells were
incubated for 10min at 37 1C and analysed by confocal micro-
scopy. Images were captured using an excitation wavelength
510 nm and an emission wavelength of 580 nm with a  40
objective. The total cell fluorescence was calculated using the
ImageJ (v1.49, NIH) software. An outline was drawn around each
individual cell, as previously described by McCloy et al (2014) the
total corrected fluorescence was then calculated as follows: total
corrected cell fluorescence (TCCF)¼ integrated density (area of
selected cellmean fluorescence of background readings).
Inhibitor studies. As indicated in the relevant figures, cells were
pre-treated for 1 h with zVAD-FMK (BD Bioscience, Oxford,
England), or were incubated with N-acetyl cysteine (NAC) (Sigma-
Aldrich) or SP600125 (Sigma-Aldrich) immediately after NTAP
treatment. Cell viability was assessed 48 h later using Alamar Blue.
Combined treatment of TMZ and NTAP. Cells were seeded at
2.5 103 cells per well in 96-well plates. Following NTAP
treatment, TMZ (Sigma-Aldrich) was added to the wells at various
concentrations. Cells were incubated for 6 days and analysed using
the Alamar blue cell viability assay.
Statistical analysis. All experiments were performed at least three
independent times with a minimum of five replicates per
experiment. Data shown are pooled and presented as mean±s.e.m.
(n¼ total number of replicates) unless stated otherwise. Statistical
analysis and curve fitting were performed using Prism 5
(GraphPad Software, Inc., La Jolla, CA, USA), as indicated in
Results. Unless otherwise indicated, differences were considered
significant with a P-value of o0.05 Correlation graphics were
attained using R statistical software (The R Foundation for
Statistical Computing, Vienna, Austria).
RESULTS
NTAP induces apoptosis in cancer cells. Previous studies have
suggested that NTAP has an antitumour effect in vitro in cell lines,
such as cervical, colorectal, lung cancer, and glioma (Ahn et al,
2011; Ko¨ritzer et al, 2013; Cheng et al, 2014; Ma et al, 2014; Siu
et al, 2015). Despite the wide range of different NTAP-generating
devices being used worldwide, evidence is emerging that cell type-
specific resistance can be observed in tumour cells and GBM cells
(and other brain-derived cells) appear to be relatively resistant to
NTAP. We compared the sensitivity of U373MG GBM cells with a
commonly used human cervical carcinoma cell line (HeLa) (Ahn
et al, 2011, 2014; Kim et al, 2014).
Dose response curves were established by first exposing cells to
NTAP for between 3 and 300 s at 75 kV, as seen in Figure 1B. Cell
viability was quantified 48h post treatment. We confirmed findings by
Ahn et al (2014) that HeLa cells are sensitive to NTAP, using our
system the IC50 value was determined to be 4.8 s (95% confidence
range of 4.2–5.6 s). U373MG GBM cells, however, exhibited a
significant increase in resistance to NTAP with an IC50 of 74.26 s (95%
confidence range of 47.24–116.8 s). A comparison of fit demonstrated
a significant difference in the IC50 values (Po0.05) between both the
U373MG and HeLa as a result of NTAP treatment, and significant
differences of the data set were confirmed using a correlation analysis
(Supplementary Figure S2). The cytotoxic response was confirmed
using the trypan blue cell membrane integrity assay, and U373MG
cells demonstrate a significantly (Po0.001) higher resistance to the
NTAP treatment than that observed by the HeLa cells after 180 s
treatment as demonstrated in Figure 1C.
DCm is an important factor of mitochondrial function and can
be an indicator of early intrinsic apoptosis. Collapse of the DCm
results in the release of cytochrome C into the cytosol, and thus
leading to cell death (Salido et al, 2007). Figure 1D demonstrates
the loss in Mitochondrial Membrane Potential (DCm) due to
NTAP treatment. Both cell lines show a significant (Po0.05) loss
in mitochondrial function, indicating a reduction in cell viability
after NTAP treatment when compared with untreated controls.
This result correlates with both the Alamar Blue and trypan blue
results, indicating that NTAP induces differential cytotoxicity in
HeLa and U373MG cells.
NTAP induces mitchondrial ROS formation in cancer cells
in situ. Recent literature using HeLa and GBM cell lines has stated
that NTAP-generated ROS causes DNA damage resulting in
apoptosis (Vandamme et al, 2012; Cheng et al, 2014). It is also well
known that mitcohondrial depolarisation can be a result of
oxidative stress produced by ROS (Ahn et al, 2011). To determine
that the cytotoxicity observed was from ROS generated by NTAP,
both cell lines were preloaded with the cell permeable ROS-
sensitive fluorescence dye, H2DCFDA. Reactive oxygen species
generation was first visualised using confocal microscopy, and we
confirmed that NTAP induced ROS-dependent H2DCFDA
fluorescence in both cell lines. The level of fluorescence in
U373MG cells appeared to be lower than that oberseved in HeLa
cells (Figure 2A), and this was then confirmed using both
spectrophotometry and flow cytometry. As seen in Figure 2B,
significantly higher levels of ROS fluorescence were observed
following NTAP treamtent in HeLa cells (Po0.05), compared with
untreated controls and with NTAP-treated U373MG cells
(Po0.05). A similar result was also obsereved by flow cytometry
as demonstrated in Figure 2C. Non-thermal atmospheric plasma
treatment demonstrated a significant increase in ROS generation
(Po0.001) compared with the untreated control in HeLa cells.
A slight dextral shift was observed in U373MG cells, but the
meausred mean fluorescence index was not signicantly altered.
Following the identification of ROS formation by H2DCFDA, cells
were treated with mitochondrial superoxide indicator, MitoSOX
red. Mitochondrial ROS production as a result of NTAP treatment
has been previuously demonstrated in HeLa cell by Ahn et al
(2014), Figure 2D demonstrates the increase in intracellular
fluorescence of mitochondrial ROS formation by confocal micr-
scopy in both HeLa and U373MG cells compared with the
untreated control. The level of fluorescence was quantified using
ImageJ (v1.49, NIH) software in both treated and untreated cells
(McCloy et al, 2014). There is a significant increase in
mitochondrial ROS after NTAP treamtent observed in both
U373MG (Po0.05) and HeLa cells (Po0.001) compared with
the untreated controls.
GBM cells demonstrate higher antioxidant activity against
H2O2. The production of a variety of ROS by NTAP, including
H2O2 has been shown previously to induce cytotoxicity (Ahn et al,
2014; Hirst et al, 2015; Xu et al, 2015). These free radicals,
particularly the NTAP-generated NO species, are believed to result
in an increase in intracellular ROS, which in turn signals a cascade
of events leading to apoptosis (Ishaq et al, 2014). As observed from
the OES data (Supplementary Figure 1), we have identifed the
presence of OH. in our OES mesurements and OH. is generated as
a result of O2
 and H2O2 interactions in the plasma field, which as
a result induces cell death (Xu et al, 2015). We hypothesised that
the increased resistance displayed by U373MG cells to NTAP could
replicated using H2O2 as an oxidative stressor. Figure 3A
demonstrates that U373MG cells indeed have an increased
tolerance for H2O2 compared with that of HeLa cells. The IC50
value for H2O2 cytotoxicity is significantly higher (Po0.0001) for
U373MG cells (544.8 mM) compared with HeLa cells (27.91 mM),
and significant differences of the data set were confirmed using a
correlation analysis (Supplementary Figure S3). The generation of
H2O2 was significantly lower in U373MG cells (EC50 458.1 mM)
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compared with HeLa cells (EC50 55.36 mM) (Figure 3B), and
significant differences of the data set were confirmed using a
correlation analysis (Supplementary Figure S4). The presence of
intracellular and mitochondrial ROS was confirmed for both cell
lines using confocal microscopy (Figure 3C).
NTAP can induces ROS-, JNK- and caspase-independent cell
death in U373MG cells. Previously, it has been reported that
NTAP induces ROS, JNK and caspase activation in cancer cells
(Vandamme et al, 2011; Hou et al, 2015; Siu et al, 2015). To
confirm the role of intracellular ROS in NTAP- and H2O2-induced
apoptosis, HeLa and U373MG cells were loaded with the well-
known thiol antioxidant NAC for 48 h after NTAP treatment. As
expected, the addition of NAC to H2O2-treated HeLa cells
(Figure 4A) and U373MG cells (Figure 4B) improved cell viability
(Po0.05), indicating that NAC was protecting against ROS-
induced cell death in both cell lines. Although NAC improved cell
viability in HeLa cells following treatment of both cells and media
with NTAP (Po0.05) (Figure 4A), there was no protective effect
noted for U373MG cells treated with NTAP (Figure 4B). There-
fore, the data strongly suggest that unlike HeLa cells, U373MG
cells undergo ROS-independent cell death in response to NTAP.
To further elucidate the molecular mechanism underlying
U373MG apoptosis following NTAP treatment, the protective effect
of increasing concentrations of the caspase inhibitor,
zVAD-FMK and the JNK inhibitor, SP600125 was determined. No
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Figure 2. NTAP demonstrates an increase in ROS formation. (A) In situ verification of ROS production in both U373MG cells and HeLa cells was
measured 1 h after NTAP exposure (75 kV for 180 s) by confocal microscopy using 10mM H2DCFDA. (B) ROS fluorescence intensity was quantified
spectrophotometrically, 1 h after NTAP exposure (75 kV for 180 s). All experiments were repeated in triplicate. Statistical analysis was carried out
using one-way ANOVA with Tukey’s multiple comparison post-test (*Po0.05). (C) ROS production in both U373MG and HeLa was also measured
by flow cytometry using 0.1mM H2DCFDA. Fluorescence was quantified using the mean H2DCFDA and compared with the untreated control
(Po0.001). (D) In situ verification of mitochondiral ROS production in both U373MG cells and HeLa cells was measured 1h after NTAP exposure
(75 kV for 180 s) by confocal microscopy using 2mM MitoSOX red. The level of fluorescence was quantified using the Image J software and
compared with the untreated control. Statisical analysis was carried out using t-test with Mann–Whitney test post-test. A full colour version of this
figure is available at the British Journal of Cancer journal online.
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significant difference in cell viability was observed with increasing
concentrations of either SP600125 (Figure 4C) or zVAD-FMK
(Figure 4D). There was also no significant difference in cell viability
if cells were treated with the inhibitor before or after NTAP treatment.
Together, our results indicate that NTAP induces apoptosis by an
ROS-, JNK- and caspase-independent manner in GBM cells.
Multiple doses and TMZ overcome the relative resistance of
U373MG cells to NTAP. If used in a clinical setting, NTAP or any
variant of this technological therapy would most likely be used
multiple times and in combination with existing chemotherapeutic
regimens. We hypothesised that multiple treatments and/or
combinational therapy with existing chemotherapeutic agents
would be sufficient to overcome the relative resistance to NTAP.
As seen in Figure 5A, triplicate NTAP exposures of 75kV for 180 s
result in a significant reduction in U373MG cell viability compared
with a single treatment (5.669–43.16%, Po0.05). Furthermore, low
doses (10 mM) of TMZ greatly augmented the cytotoxicity observed
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concentrations of H2O2 (0–2mM). After 48 h cells were analysed using the Alamar Blue assay. All experiments were repeated at least three times.
Statistical analysis was carried out using non-linear regression analyses. (B) Both U373MG cells and HeLa cells were preloaded for 1 h with 10 mM
H2DCFDA. H2DCFDA was removed and a dose-response analysis was performed using H2O2. The relative increase in fluroescence was
determined 1 h after the addition of H2O2. Statistical analyses were carried out using non-linear regression analyses. All experiments were
repeated minimum in triplicate. (C) In situ verification of ROS production in both U373MG cells and HeLa cells, which was measured 1h after the
addition of H2O2 by confocal microscopy using both 10mM H2DCFDA and 2 mM MitoSOX red, is shown. A full colour version of this figure is
available at the British Journal of Cancer journal online.
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Figure 4. NTAP induces ROS-, JNK- and caspase-independent cytotoxicity in glioma cells. Both HeLa (A) and U373MG (B) cells were preloaded
for 1 h with 4mM NAC. Cells were then treated with H2O2 or exposed to NTAP. After 48 h, cell was analysed using the Alamar blue assay. Data
shown were normalised to the untreated control and are shown as the % mean±s.e.m. (n¼minimum 20). All experiments were repeated at least
three times. Statistical analysis was carried out using one-way ANOVA with Tukey’s multiple comparison post test (*Po0.05). (C) Following NTAP
treamtent, cells were loaded with increasing concentrations of SB600125 (0–50mM) inhibitor and incubated for 48 h. Cells were then analysed using
Alamar blue cell viability assay. (D) U373MG cells were pretreated with increasing concentrations of zVAD-FMK for 1h before NTAP treatment. Cells
were then incubated for 48h and analysed by Alamar blue. Data shown were normalised to the untreated control and are shown as the %
mean±s.e.m. (n¼minimum 20). All experiments were repeated at least three times.
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due to NTAP with toxicity levels approaching 80–100%
(Figure 5B). Two-way ANOVA confirmed that there is variance
in the data due to the combination of TMZ and NTAP, which
cannot be explained by TMZ and NTAP alone. This indicates the
presence of a synergistic effect as observed on the graph
(Figure 5B) at 30 s NTAP and 10 mM TMZ with Po0.0001. The
IC50 for TMZ was determined to be 13mM over a 6-day time course
(data not shown).
DISCUSSION
GBMs are very aggressive and are resistant to most chemotherapies
and radiation therapy (Curtin et al, 2005). Advances in wearable
medical devices have led to the possibility of replacing or
complementing existing chemotherapies using a technology-based
approach. In this regard, there has been substantial development in
the area of plasma medicine over the past decade, including the use
of NTAP as a potential therapy for the treatment of cancer. It has
been documented that ROS generated by NTAP treatment can
induce apoptosis in glioma cells as well as many other cancer cells
(Vandamme et al, 2012; Ahn et al, 2014; Siu et al, 2015). Our OES
measurements confirmed notably larger emissions for nitrogen
species and very little emissions at the atomic oxygen region of 777
and 845 nm, in agreement with those reported by others using
unmodified atmospheres and are as a result of quenching with N2
and O2 (Walsh et al, 2010; Misra et al, 2014). The presence of
atomic oxygen is not required for the generation of ROS. Non-
thermal atmospheric plasma generated NO results in intensifica-
tion of intracellular NO concentration that initiates a cascade of
event, subsequently increases intracellular ROS (Vandamme et al,
2012; Ishaq et al, 2014). In accordance with previous studies, the
antiproliferative effect of NTAP treatment was confirmed in vitro
(Ahn et al, 2011; Vandamme et al, 2012). The resistance to H2O2-
induced apoptosis has been reported previously in GBM cells
(Datta et al, 2002), but to the best of our knowledge, ROS-
independent NTAP cytotoxicity has yet to be reported and
characterised. We demonstrate here that U373MG GBM cells
display a significant resistance to cytotoxicity and ROS generation
(Po0.0001) when compared with a commonly studied NTAP-
sensitive cancer cell line HeLa.
The current standard of care for the treatment of glioma
involves repeated exposure to chemotherapy/radiation over a
period of weeks/months in order to ensure eradication of the entire
tumour. A similar effect was demonstrated with multiple exposures
to NTAP, a triple exposure over a 10-h period greatly enhanced
cytotoxicity of the U373MG cells, indicating that NTAP can be
both effective and cumulative against GBM. In the current clinical
setting, radiation therapy is used in combination with surgery and
chemotherapy to treat GBM. Non-thermal atmospheric plasma is
also based on the formation of intracellular chemically active
species. As the technology develops, the primary advantage of
NTAP over radiotherapy will be the ability to generate these
species in situ, at the site of the tumour and reduce the resulting
systemic side effects (Ishaq et al, 2014). Moreover, the species
generated by NTAP are short lived in comparison with the
relatively long-lived radioactive isotopes introduced during radia-
tion therapy (Stoffels et al, 2008). We were able confirm the
generation of ROS by NTAP treatment in HeLa cells as previously
reported by Ahn et al (2011). Reactive oxygen species generation
was also observed in NTAP-treated U373MG cells (Figure 2) but,
interestingly, at a significantly lower level compared with NTAP-
treated HeLa cells. These results echoed H2O2-induced ROS levels,
indicating that U373MG cells have a 5- to 10-fold greater capacity
to neutralise ROS compared with HeLa cells.
ROS, JNK and caspase activation have all been reported in
cancer cells following NTAP treatment (Vandamme et al, 2011;
Hou et al, 2015; Siu et al, 2015). We hypothesised that by activating
multiple cell death pathways together, specific inhibition of these
pathways would not be preventative of cell death after longer
treatments of NTAP in U373MG cells. To test this hypothesis, we
titrated common inhibitors of ROS, JNK and caspases. In line with
previous findings (Ko¨ritzer et al, 2013), we found that caspase
inhibitors do not protect against the effects of NTAP treatment.
Furthermore, we were unable to protect against cell death using
ROS scavengers or JNK inhibitors in GBM cells. It has been
hypothesised that NTAP offers great potential as a possible therapy
for the treatment of GBM due to the wide variety of biological
processes affected and our own data are supporting this hypothesis.
Our data suggest that several pathways have been activated
simultaneously by the NTAP treatment, and blocking individual
pathways is insufficient to inhibit cell death. To the best of our
knowledge, this is the first evidence of a cell line where NTAP
treatment can induce cell death even in the presence of JNK,
Caspases and ROS inhibitors. In contrast to the results observed for
HeLa cells, cytotoxicity in U373MG cells following NTAP treatment
is not alleviated by the presence of NAC. N-acetyl cysteine does
protect against high concentrations (2mM) of H2O2 in U373MG
cells. Therefore, NTAP is primarily inducing cell death through a
H2O2- and ROS-independent mechanism in U373MG cells.
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Figure 5. Synergy observed between TMZ and NTAP. (A) The effects of multiple NTAP exposures were determined in both HeLa and U373MG.
Cells were exposed three times within a 10-h period with a minimum 4h between treatments. Forty-eight hours later, cells were then analysed
using the Alamar blue assay. Results are shown as the mean±s.e.m. (n¼ minimum 24). Statistical analysis was carried out using one-way ANOVA
with Tukey’s multiple comparison post-test (*Po0.05 against untreated control). (B) Following NTAP treatment, cells were treated with low
concentrations of TMZ. Cells were incubated for 6 days and analysed by Alamar blue assay. Data shown were normalised to the untreated control
and are shown as the % mean±s.e.m. (n¼minimum 20). Statistical analysis was carried out using two-way ANOVA with Bonferroni post test
(*Po0.001). All experiments were repeated at least three times.
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We observed that U373MG cells were relatively resistant to
NTAP treatment, and so we looked at techniques to overcome this.
We found that both multiple exposures to NTAP and use of low
concentrations of TMZ were sufficient to overcome the relative
resistance of U373MG cells to NTAP. Both these approaches led to
an improved cytotoxicity of between 80% and 95%, which is
similar in magnitude to that observed when we use NTAP-sensitive
cells such as HeLa cells (data not shown). Harsh side effects are
associated with existing standard of care for patients diagnosed
with GBM and despite this; very limited gains in long-term survival
are evident. Therefore, lower doses of TMZ when used in
combination with NTAP may lead to a more effective treatment
while reducing the harmful side effects. Future development of
micro-plasma technologies will greatly facilitate this specific
targeting of GBM cells in the brain.
In conclusion, for the very first time, we report that NTAP
induces an ROS-, JNK- and caspase-independent mechanism of
cell death in the U373MG GBM cells that can be greatly enhanced
when used in combination with low doses of TMZ or with
cumulative exposures to NTAP. This highlights the potential of
in situ NTAP generation as a future brain cancer therapy. Further
refinement of the technology will be necessary and the generation
of micro-scale plasma fields promises to facilitate localised
activation of cytotoxicity against GBM cells when used in
combination with new and existing chemotherapeutic regimens.
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